CENSO BIOTECHNOLOGIES LTD

Active Midlothian

Research and experimental development on biotechnology

39 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CENSO BIOTECHNOLOGIES LTD

Research and experimental development on biotechnology

Founded 9 Sept 2008 Active Midlothian, Scotland 39 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

ROSLIN CELLAB LIMITED 9 Sept 2008 — 5 May 2016
Accounts Due 30 Sept 2026 3 months remaining
Confirmation
Net assets £8M £3M 2023 year on year
Total assets £11M £2M 2023 year on year
Total Liabilities £3M £677K 2023 year on year
Charges 3
3 outstanding

Contact & Details

Contact

Registered Address

Roslin Innovation Centre Charnock Bradley Building Easter Bush Campus Midlothian EH25 9RG Scotland

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CENSO BIOTECHNOLOGIES LTD (SC348293), an active life sciences and medical technology company based in Midlothian, Scotland. Incorporated 9 Sept 2008. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2023)

Cash in Bank

£457.47k

Decreased by £330.38k (-42%)

Net Assets

£7.96M

Decreased by £2.63M (-25%)

Total Liabilities

£2.86M

Increased by £676.50k (+31%)

Turnover

N/A

Employees

39

Decreased by 4 (-9%)

Debt Ratio

26%

Increased by 9 (+53%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

22 Allotments 2,027,608 Shares £13.99m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Dec 2025104,525£462k£4.42
24 Dec 202535,335£184k£5.22
24 Dec 202515,878£79k£4.99
17 Mar 20253,239£14k£4.42
3 Jul 20244,525£20k£4.42

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (230)

Calculus Nominees Ltd
10.8%
404,794
Yichen Shi
8.8%
328,136

Persons with Significant Control

Persons with Significant Control (0)

0 Active 5 Ceased

Roslin Cells Limited

Ceased 28 Mar 2018

Ceased

Roslin Foundation

Ceased 23 Aug 2019

Ceased

Genomia Management Limited

Ceased 16 Mar 2021

Ceased

Roslin Foundation

Ceased 28 Mar 2018

Ceased

Aidan Benedict Courtney

Ceased 23 Aug 2019

Ceased

Group Structure

Group Structure

CENSO BIOTECHNOLOGIES LTD Current Company
AXOL BIOSCIENCE LTD united kingdom

Charges

Charges

3 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 May 2026OfficersChange Corporate Secretary Company With Change Date
12 May 2026CapitalAllotment of shares (GBP 252,216.59) on 28 Apr 2026
16 Jan 2026MiscellaneousReplacement filing of SH01 - 24/12/25 Statement of Capital gbp 252137.40
7 Jan 2026CapitalAllotment of shares (GBP 252,137.4) on 24 Dec 2025
5 Jan 2026ResolutionResolutions
20 May 2026 Officers

Change Corporate Secretary Company With Change Date

12 May 2026 Capital

Allotment of shares (GBP 252,216.59) on 28 Apr 2026

16 Jan 2026 Miscellaneous

Replacement filing of SH01 - 24/12/25 Statement of Capital gbp 252137.40

7 Jan 2026 Capital

Allotment of shares (GBP 252,137.4) on 24 Dec 2025

5 Jan 2026 Resolution

Resolutions

Recent Activity

Latest Activity

Change Corporate Secretary Company With Change Date

2 weeks ago on 20 May 2026

Allotment of shares (GBP 252,216.59) on 28 Apr 2026

3 weeks ago on 12 May 2026

Replacement filing of SH01 - 24/12/25 Statement of Capital gbp 252137.40

4 months ago on 16 Jan 2026

Allotment of shares (GBP 252,137.4) on 24 Dec 2025

5 months ago on 7 Jan 2026

Resolutions

5 months ago on 5 Jan 2026